CN Stock MarketDetailed Quotes
300485 Beijing Science Sun Pharmaceutical
- 8.23
- -0.14-1.67%
Market Closed Dec 13 15:00 CST
3.96BMarket Cap-20.68P/E (TTM)
8.36High8.20Low49.25KlotVolume8.32Open8.37Pre Close40.82MTurnover1.80%Turnover Ratio38.46P/E (Static)481.67MShares10.9252wk High1.19P/B2.25BFloat Cap5.7352wk Low10.04Limit Up273.82MShs Float43.34Historical High6.70Limit Down1.91%Amplitude5.73Historical Low0.02Dividend TTM8.29Avg Price22.85KlotAsk0.27%Div YieldTTM100Lot Size25.24KlotBid
Beijing Science Sun Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -22.61%331.47M | -25.78%221.57M | -25.36%112.74M | -32.75%530.71M | -31.77%428.3M | -27.60%298.52M | -28.31%151.05M | -31.77%789.1M | -29.32%627.73M | -27.02%412.33M |
| Refunds of taxes and levies | -82.56%2.19M | -82.56%2.19M | ---- | --0 | 5,204.83%12.55M | --12.55M | ---- | --2.61M | --236.5K | ---- |
| Cash received relating to other operating activities | 36.35%8.16M | -25.03%1.87M | -37.72%1.36M | -74.61%3.91M | -35.89%5.99M | -72.97%2.49M | -64.07%2.19M | -41.40%15.4M | -0.78%9.34M | 42.31%9.21M |
| Cash inflows from operating activities | -23.50%341.82M | -28.04%225.63M | -25.54%114.1M | -33.76%534.62M | -29.89%446.83M | -25.62%313.56M | -29.31%153.24M | -31.76%807.11M | -29.00%637.3M | -26.24%421.54M |
| Goods services cash paid | -40.27%67.68M | -38.54%46.87M | -36.84%23.28M | 26.92%123.29M | 34.32%113.31M | 25.96%76.26M | 15.90%36.85M | -19.57%97.14M | -32.32%84.36M | -25.98%60.54M |
| Staff behalf paid | -10.34%58.39M | -8.40%39.39M | -3.12%18.87M | -9.67%82.87M | -3.34%65.12M | -8.89%43M | 8.79%19.48M | -15.41%91.74M | -17.67%67.37M | -14.87%47.2M |
| All taxes paid | -50.66%14.53M | -39.89%13.8M | -52.85%3.75M | -54.53%23.57M | -16.94%29.46M | 10.88%22.95M | -53.70%7.96M | -40.19%51.84M | -44.89%35.46M | -46.59%20.7M |
| Cash paid relating to other operating activities | -52.82%95.76M | -61.49%55.24M | -69.01%26.09M | -37.78%283.68M | -43.62%202.94M | -39.69%143.46M | -36.38%84.19M | -33.29%455.96M | -28.11%359.97M | -24.04%237.86M |
| Cash outflows from operating activities | -42.47%236.36M | -45.64%155.3M | -51.51%71.99M | -26.31%513.41M | -24.92%410.83M | -22.01%285.67M | -25.47%148.47M | -30.29%696.68M | -29.08%547.16M | -25.11%366.3M |
| Net cash flows from operating activities | 192.90%105.46M | 152.19%70.33M | 783.06%42.11M | -80.79%21.21M | -60.06%36.01M | -49.52%27.89M | -72.86%4.77M | -39.75%110.43M | -28.47%90.14M | -32.93%55.24M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -47.35%36.35M | -36.53%22.89M | -19.81%11.32M | 2,391.81%98.24M | 1,651.19%69.04M | 814.89%36.07M | 258.18%14.12M | -82.34%3.94M | -82.34%3.94M | -57.16%3.94M |
| Cash received from returns on investments | 46.28%14.8M | 30.79%10.87M | 252.40%13.43M | -60.91%15.61M | -65.19%10.12M | -31.82%8.31M | 22.03%3.81M | -10.22%39.92M | -8.16%29.06M | -38.26%12.19M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | -99.73%30K | -99.72%30K | -99.91%10K | -99.87%2.25K | -28.46%10.91M | 458.44%10.8M | --10.9M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash received relating to other investing activities | -67.98%321.83M | -68.82%247.64M | -66.84%140.08M | -51.93%791.11M | -21.02%1.01B | 25.04%794.2M | -4.82%422.38M | 16.17%1.65B | 192.03%1.27B | 28.00%635.17M |
| Cash inflows from investing activities | -65.60%372.98M | -66.44%281.4M | -62.56%164.83M | -46.78%904.99M | -17.63%1.08B | 26.64%838.59M | -2.72%440.32M | 13.46%1.7B | 167.74%1.32B | 26.09%662.2M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 32.74%55.79M | 80.66%41.15M | -21.23%6.31M | 22.24%52.91M | 97.01%42.03M | 416.92%22.78M | 100.61%8.02M | -5.73%43.28M | 61.16%21.34M | -80.13%4.41M |
| Cash paid to acquire investments | -81.13%10M | ---- | ---- | -74.17%53M | 12.29%53M | -5.00%38M | ---- | 110.15%205.2M | -46.15%47.2M | -54.36%40M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --4.43M | ---- | ---- |
| Cash paid relating to other investing activities | -59.02%413.61M | -54.89%349.1M | -57.49%194.6M | -37.43%885.34M | -22.50%1.01B | 20.68%773.94M | 15.02%457.76M | -29.86%1.42B | 70.68%1.3B | -12.39%641.31M |
| Cash outflows from investing activities | -56.59%479.41M | -53.25%390.25M | -56.86%200.91M | -40.57%991.25M | -19.44%1.1B | 21.73%834.72M | 15.87%465.78M | -22.82%1.67B | 58.68%1.37B | -18.54%685.72M |
| Net cash flows from investing activities | -435.31%-106.42M | -2,911.16%-108.85M | -41.69%-36.08M | -366.32%-86.26M | 63.36%-19.88M | 116.47%3.87M | -150.31%-25.47M | 104.89%32.39M | 85.42%-54.26M | 92.57%-23.52M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --720K | --570K | --220K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --720K | --570K | --220K |
| Cash from borrowing | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash inflows from financing activities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --720K | --570K | --220K |
| Borrowing repayment | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Dividend interest payment | -74.42%10.59M | -74.42%10.59M | ---- | -48.82%41.4M | -48.82%41.4M | -48.82%41.4M | ---- | 158.33%80.88M | 158.39%80.88M | 158.39%80.88M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash payments relating to other financing activities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash outflows from financing activities | -74.42%10.59M | -74.42%10.59M | ---- | -48.82%41.4M | -48.82%41.4M | -48.82%41.4M | ---- | 158.33%80.88M | 158.39%80.88M | 158.39%80.88M |
| Net cash flows from financing activities | 74.42%-10.59M | 74.42%-10.59M | ---- | 48.36%-41.4M | 48.45%-41.4M | 48.68%-41.4M | ---- | -156.03%-80.16M | -156.57%-80.31M | -157.69%-80.66M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -135.73%-261.95K | -83.07%150.66K | 113.30%42.02K | -79.86%402.71K | -70.17%733.19K | -21.92%889.9K | -238.32%-315.88K | 494.67%2M | 1,931.94%2.46M | 617.70%1.14M |
| Net increase in cash and cash equivalents | 51.87%-11.81M | -459.72%-48.96M | 128.91%6.08M | -263.99%-106.05M | 41.53%-24.54M | 81.70%-8.75M | -130.86%-21.01M | 112.66%64.67M | 84.88%-41.96M | 82.02%-47.79M |
| Add:Begin period cash and cash equivalents | -46.88%120.16M | -46.88%120.16M | -46.88%120.16M | 40.03%226.21M | 40.03%226.21M | 40.03%226.21M | 40.03%226.21M | -75.98%161.54M | -75.98%161.54M | -75.98%161.54M |
| End period cash equivalent | -46.27%108.35M | -67.26%71.2M | -38.48%126.24M | -46.88%120.16M | 68.65%201.67M | 91.18%217.46M | -10.64%205.2M | 40.03%226.21M | -69.72%119.58M | -72.03%113.75M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
